FeaturedNeurologyNeuroscience·March 27, 2021·4 min readCommon Alzheimer’s Treatment Linked to Slower Cognitive DeclineCholinesterase inhibitors such as galantamine, donepezil, and rivastigmine, appear to generate persistent cognitive benefits, and increased longevity for up to five years in Alzheimer's patients.Read More
FeaturedNeurologyNeuroscience·October 3, 2019·3 min readPesticides likely caused ‘Havana syndrome’ that affected Cuba-based diplomatsInitially believed to be an acoustic attack, researchers now believe they have pinpointed a possible cause of the bizarre neurological symptoms reported by diplomats in Cuba in 2016. Researchers say a possible source for 'Havana syndrome' is exposure to cholinesterase inhibitors via organophosphorus insecticides.Read More
FeaturedNeurology·November 10, 2017·3 min readSmell Test Challenge Suggests Clinical Benefit for Some Before Development of Alzheimer’sColumbia researchers have identified a way in which to determine if a patient with MCI may respond to cholinesterase inhibitors.Read More
FeaturedNeurologyOpen Neuroscience Articles·February 23, 2016·3 min readBrain Injury Recovery Boosted by Longer and More Intense RehabilitationLonger and more intense rehabilitation following stroke or TBI may produce greater benefits for recovery, a new study reports.Read More
FeaturedNeuroscience·May 7, 2013·3 min readTurning Alzheimer’s Fuzzy Signals Into High DefinitionResearchers have discovered how cholinesterase inhibitors, a class of drug that prevents the breakdown of acetylcholine, could sharpen the brain's performance in patients with Alzheimer's disease.Read More